Corrigendum to “Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation” [Contemp. Clin. Trials Commun. 33 (2023) 101144]

Corrigendum to “Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation” [Contemp. Clin. Trials Commun. 33 (2023) 101144]

[This corrects the article DOI: 10.1016/j.conctc.2023.101144.].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Contemporary clinical trials communications 2024-06, Vol.39, p.101302, Article 101302
Hauptverfasser: Cuffari, Carmen, Spalding, William, Achenbach, Heinrich, Thakur, Manoj, Gabriel, André
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[This corrects the article DOI: 10.1016/j.conctc.2023.101144.].
ISSN:2451-8654
2451-8654
DOI:10.1016/j.conctc.2024.101302